BlackRock
VANI icon

BlackRock’s Vivani Medical VANI Stock Holding History

BlackRock’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
297,498
+61,436
+26% +$76.8K ﹤0.01% 4655
2025
Q4 		$290K Buy
236,062
+146,950
+165% +$212K ﹤0.01% 4622
2025
Q3 		$126K Buy
89,112
+703
+0.8% +$953 ﹤0.01% 4786
2025
Q2 		$114K Buy
88,409
+18,710
+27% +$20.6K ﹤0.01% 4806
2025
Q1 		$73.2K Sell
69,699
-993
-1% -$1.14K ﹤0.01% 4838
2024
Q4 		$82K Sell
70,692
-275
-0.4% -$348 ﹤0.01% 4833
2024
Q3 		$83K Buy
70,967
+1,986
+3% +$2.48K ﹤0.01% 4712
2024
Q2 		$86.9K Buy
68,981
+15,257
+28% +$26.2K ﹤0.01% 4734
2024
Q1 		$99.4K Sell
53,724
-3,482
-6% -$5.13K ﹤0.01% 4731
2023
Q4 		$58.4K Sell
57,206
-630
-1% -$624 ﹤0.01% 4938
2023
Q3 		$59K Sell
57,836
-156,561
-73% -$172K ﹤0.01% 4972
2023
Q2 		$259K Sell
214,397
-97,677
-31% -$120K ﹤0.01% 4667
2023
Q1 		$312K Sell
312,074
-4,070
-1% -$4.52K ﹤0.01% 4662
2022
Q4 		$269K Sell
316,144
-5,538
-2% -$9.02K ﹤0.01% 4772
2022
Q3 		$734K Buy
321,682
+293,777
+1,053% +$1.39M ﹤0.01% 4590
2022
Q2 		$169K Buy
27,905
+3,119
+13% +$16.8K ﹤0.01% 5081
2022
Q1 		$106K Buy
24,786
+1,511
+6% +$6.35K ﹤0.01% 5273
2021
Q4 		$114K Buy
23,275
+1,158
+5% +$8.47K ﹤0.01% 5231
2021
Q3 		$212K Sell
22,117
-129,464
-85% -$1.46M ﹤0.01% 4971
2021
Q2 		$2.25M Buy
151,581
+25,569
+20% +$494K ﹤0.01% 4220
2021
Q1 		$3.12M Buy
126,012
+113,077
+874% +$1.69M ﹤0.01% 4145
2020
Q4 		$72K Buy
12,935
+85
+0.7% +$300 ﹤0.01% 4628
2020
Q3 		$33K Buy
12,850
+1
+0% +$3 ﹤0.01% 4659
2020
Q2 		$38K Sell
12,849
-103
-0.8% -$366 ﹤0.01% 4613
2020
Q1 		$39K Buy
12,952
+1,141
+10% +$15.1K ﹤0.01% 4521
2019
Q4 		$211K Buy
11,811
+10
+0.1% +$196 ﹤0.01% 4308
2019
Q3 		$234K Buy
11,801
+35
+0.3% +$690 ﹤0.01% 4306
2019
Q2 		$226K Sell
11,766
-2,413
-17% -$49.5K ﹤0.01% 4341
2019
Q1 		$271K Sell
14,179
-162
-1% -$3.15K ﹤0.01% 4200
2018
Q4 		$305K Sell
14,341
-9
-0.1% -$286 ﹤0.01% 4153
2018
Q3 		$655K Sell
14,350
-120
-0.8% -$4.84K ﹤0.01% 4070
2018
Q2 		$576K Buy
14,470
+897
+7% +$39K ﹤0.01% 4059
2018
Q1 		$626K Buy
13,573
+415
+3% +$18.5K ﹤0.01% 4009
2017
Q4 		$603K Buy
13,158
+102
+0.8% +$3.39K ﹤0.01% 4027
2017
Q3 		$376K Sell
13,056
-472
-3% -$13.2K ﹤0.01% 4108
2017
Q2 		$409K Sell
13,528
-23,903
-64% -$676K ﹤0.01% 4075
2017
Q1 		$1.09M Buy
37,431
+37,423
+467,788% +$1.43M ﹤0.01% 3797
2016
Q4 		$0 Hold
8
– – ﹤0.01% 3815
2016
Q3 		$1K Hold
8
– – ﹤0.01% 3662
2016
Q2 		$1K Buy
8
+1
+14% +$104 ﹤0.01% 3690
2016
Q1 		$1K Buy
+7
New +$806 ﹤0.01% 3566

Other funds holding VANI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

BlackRock's VANI Position: Q1 2026 in Review

BlackRock increased its Vivani Medical (VANI) stake by 26% in Q1 2026, buying an estimated $76.8K and bringing the position to 297,498 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #4655.

BlackRock first reported a position in VANI in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.12M in Q1 2021. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.

  • BlackRock held 297,498 shares of Vivani Medical worth $297K as of Q1 2026.
  • BlackRock bought 61,436 Vivani Medical shares in Q1 2026, an estimated $76.8K.
  • Vivani Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4655 holding.
  • BlackRock first reported a position in Vivani Medical in Q1 2016 and has held it in 41 quarters since.
  • BlackRock's Vivani Medical position peaked at $3.12M in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.